Empagliflozin Reduces Realworld Heart Failure Hospitalization In Type 2 Diabetes | Latest News RSS feed

Empagliflozin Reduces Realworld Heart Failure Hospitalization In Type 2 Diabetes - Latest News


Diabetes Drug Jardiance Reduces Heart Disease Death

About two of every three people with type 2 diabetes die of heart disease or stroke, the American Diabetes Association says. In the new study, Jardiance helped prevent ... death [from any cause] by 32 ... read more

Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization

CHICAGO — Patients with type 2 diabetes (T2D) treated with empagliflozin as part of routine clinical care, experienced a decrease in risk of heart failure hospitalization, according to research ... read more

EMPA-HEART: Empagliflozin May Reduce LV Mass in Patients With CVD, Diabetes

CHICAGO — Treatment with the sodium glucose cotransporter-2 ... type 2 diabetes, especially if they have a history of heart failure and especially if they have a history of coronary heart disease," ... read more

Looking for another news?


ACC Pathway Finds Empagliflozin "Preferred" SGLT2 Therapy for Patients With Type 2 Diabetes, ASCVD

in hospitalization for heart failure, an area that would attract more interest as real-world data produced similar findings. In December 2016, empagliflozin became the first drug to receive an FDA ... read more


SGLT-2 Inhibitors: Newer Type 2 Diabetes Drugs Prevent Heart Failure

Newer type ... 2 (Sodium glucose co-transporter 2) inhibitors was found to significantly reduce the risk of death and hospitalization for heart failure patients when compared to other medications that ... read more

Lilly: Jardiance Reduces Risk Of Cardiovascular Death In Type 2 Diabetes And PAD

(RTTNews) - New data presented showed that Jardiance reduced the risk of cardiovascular death compared with placebo when added to standard of care in adults with type 2 diabetes and ... by 38 percent ... read more

Addressing the Risk of Cardiovascular Mortality in Adult Patients with Type 2 Diabetes and Established Cardiovascular Disease

7 Reports of ketoacidosis, a serious life-threatening condition requiring urgent hospitalization ... empagliflozin. JARDIANCE is indicated to reduce the risk of cardiovascular (CV) death in adults ... read more

Type 2 diabetes drug significantly reduces hospitalizations, death from heart failure

For the first time, research shows that a type 2 diabetes drug significantly reduces hospitalizations ... and risk factors for heart disease were randomized to receive once-daily doses of either the ... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data ... read more

Empagliflozin Cuts CVD Risk in Patients With Type 2 Diabetes, PAD

Data from this patient group showed that empagliflozin cut the risk of cardiovascular death by 43% compared with placebo. All-cause mortality was lowered by 38% and hospitalization for heart failure . ... read more

Research in the news: Diabetes drug reduces risk of heart failure and may prevent it, study shows

For the first time, research shows that a type 2 diabetes drug significantly reduces hospitalizations ... and risk factors for heart disease were randomized to receive once-daily doses of either the ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us